Add Yahoo as a preferred source to see more of our stories on Google. An exterior view of 23andMe's former headquarters in South San Francisco, Calif. (Image via Google Streetview) On Tuesday, a ...

23andMe, a popular direct-to-consumer genetic testing company, made headlines after its CEO pledged to help reunite the more than 2,300 children separated from their parents at the U.S.’s southern ...

Genetic testing company 23andMe announced on Sunday that it has filed for bankruptcy due to low demand for its ancestry kits and after a 2023 data breach damaged its reputation. The company, which has ...

Once a promising company briefly valued at $6 billion, 23andMe popularized at-home DNA test kits and spawned a cottage industry of ancestry hunters and true crime sleuths. But the company could not ...

Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM Research Institute will ...

Genetic testing company 23andMe (NASDAQ:ME) has filed for Chapter 11 bankruptcy protection in a Missouri federal court, marking a dramatic fall for a company once valued at nearly US$6 billion.

Personal genetics company 23andMe is betting that its at-home DNA testing kit can help users identify the likelihood of developing diabetes. 23andMe is upgrading its at-home DNA testing kit to include ...

Genetic testing company 23andMe filed for bankruptcy on March 23, 2025. The move comes after years of public mistrust, and significant legal costs stemming from a 2023 data breach involving 6.9 ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s privacy ...

Direct-to-consumer genetic testing now a booming industry—and it’s easy to see why. A simple swap of the inside of your mouth can provide you with insights into your ethnicity, health, and long-lost ...

23andMe Holding Co.'s stock tumbled 47% Monday, after the DNA-testing company filed for Chapter 11 bankruptcy, just months after admitting there was substantial doubt about its ability to continue as ...